🔎 Trials Near Me

Avaleht › Astma › Kentucky

Astma kliinilised uuringud osariigis Kentucky

7 uuringut haiguse Astma jaoks otsivad osalejaid osariigis Kentucky.

Ametlik uuringutekst (inglise keeles)

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

  • GSK Investigational Site, Owensboro
VärbamineFaas 3
Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07645248

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Owensboro
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 30. sept 2026 · NCT05757102

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  • Research Site, Louisville
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 25. sept 2026 · NCT06932263

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, Owensboro
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 24. sept 2026 · NCT07301255

A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma

  • Allergy & Asthma Specialists, P.S.C., Owensboro
VärbamineFaas 2
Vanused 18–75 · Kõik sood · Uuendatud 22. sept 2026 · NCT07219173

A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma

  • Research Site, Owensboro
VärbamineFaas 2
Vanused 4–11 · Kõik sood · Uuendatud 27. aug 2026 · NCT07525375

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

  • Research Site, Louisville
  • Research Site, Louisville
VärbamineFaas 3
Vanused 12–17 · Kõik sood · Uuendatud 13. aug 2026 · NCT06307665

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.